



Fifty percent had a BT > 37 ☌ on the initial presentation and 78.5% of patients developed BT > 37 ☌ during the course of the disease. After excluding patients with missing temperature data ( n = 1802), 7614 patients were included in the analysis (Table 1). A total of 9417 patients tested positive for the SARS-CoV-2 virus by RT-PCR detection. We analyzed BT data in the de-identified database of COVID-19-suspected patients in Mount Sinai and its affiliated hospitals in the New York area as of May 3, 2020. We sought to analyze how BT monitoring might inform mortality rate estimates in COVID-19-positive patients. However, there are currently no published studies that have looked at body temperature (BT) as a potential prognostic marker. The degree of temperature elevation might reflect the severity of inflammation. One factor that is common to the majority of hospitalized COVID-19 patients is fever. The high mortality rate, lack of effective therapies, and extremely high volume of cases have led to a clear need for reliable prognostic markers to indicate which patients are at the highest risk of death and thus require closer monitoring. Treatment options for severe cases remain limited. Systemic inflammation that accompanies acute respiratory distress syndrome in COVID-19 is associated with a high mortality rate, as high as 32.5%. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
